CombiMatrix Corporation Appoints Richard Ding and Joseph M. Limber to Board of Directors

IRVINE, Calif., March 1, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that two veteran healthcare executives have been appointed to the Board of Directors, effective immediately. The addition of the new directors brings the total number of board members to nine.